Targeting the autophagy pathway for cancer chemoprevention

Current Opinion in Cell Biology

Volumn 22, Issue 2, 2010, Pages 218-225

  Steeves, Meredith A ^a   Dorsey, Frank C ^a   Cleveland, John L ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BECLIN 1; CHLOROQUINE; METFORMIN;

ANTINEOPLASTIC ACTIVITY; AUTOPHAGY; CALORIC RESTRICTION; CANCER CELL; CANCER PREVENTION; CELL AGING; CELL DAMAGE; DNA DAMAGE; FOOD COMPOSITION; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOSURVEILLANCE; MALIGNANT NEOPLASTIC DISEASE; MALIGNANT TRANSFORMATION; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; AUTOPHAGY; CELL TRANSFORMATION, NEOPLASTIC; CHEMOPREVENTION; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 77951233877     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ceb.2009.12.013     Document Type: Review

References (77)

1. Degenhardt K., Mathew R., Beaudoin B., Bray K., Anderson D., Chen G., Mukherjee C., Shi Y., Gelinas C., Fan Y., et al. Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell 2006, 10:51-64.
2. Amaravadi R.K., Yu D., Lum J.J., Bui T., Christophorou M.A., Evan G.I., Thomas-Tikhonenko A., Thompson C.B. Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. J Clin Invest 2007, 117:326-336.
3. Levine B., Deretic V. Unveiling the roles of autophagy in innate and adaptive immunity. Nat Rev Immunol 2007, 7:767-777.
4. Lum J.J., Bauer D.E., Kong M., Harris M.H., Li C., Lindsten T., Thompson C.B. Growth factor regulation of autophagy and cell survival in the absence of apoptosis. Cell 2005, 120:237-248.
5. Pattingre S., Tassa A., Qu X., Garuti R., Liang X.H., Mizushima N., Packer M., Schneider M.D., Levine B. Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 2005, 122:927-939.
6. Tracy K., Dibling B.C., Spike B.T., Knabb J.R., Schumacker P., Macleod K.F. BNIP3 is an RB/E2F target gene required for hypoxia-induced autophagy. Mol Cell Biol 2007, 27:6229-6242.
7. Levine B., Kroemer G. Autophagy in the pathogenesis of disease. Cell 2008, 132:27-42.
8. Liang C., Feng P., Ku B., Dotan I., Canaani D., Oh B.H., Jung J.U. Autophagic and tumour suppressor activity of a novel Beclin1-binding protein UVRAG. Nat Cell Biol 2006, 8:688-699.
9. Takahashi Y., Coppola D., Matsushita N., Cualing H.D., Sun M., Sato Y., Liang C., Jung J.U., Cheng J.Q., Mule J.J., et al. Bif-1 interacts with Beclin 1 through UVRAG and regulates autophagy and tumorigenesis. Nat Cell Biol 2007, 9:1142-1151.
10. Marino G., Salvador-Montoliu N., Fueyo A., Knecht E., Mizushima N., Lopez-Otin C. Tissue-specific autophagy alterations and increased tumorigenesis in mice deficient in Atg4C/autophagin-3. J Biol Chem 2007, 282:18573-18583.
11. Karantza-Wadsworth V., Patel S., Kravchuk O., Chen G., Mathew R., Jin S., White E. Autophagy mitigates metabolic stress and genome damage in mammary tumorigenesis. Genes Dev 2007, 21:1621-1635.
12. Mathew R., Kongara S., Beaudoin B., Karp C.M., Bray K., Degenhardt K., Chen G., Jin S., White E. Autophagy suppresses tumor progression by limiting chromosomal instability. Genes Dev 2007, 21:1367-1381.
13. Aita V.M., Liang X.H., Murty V.V., Pincus D.L., Yu W., Cayanis E., Kalachikov S., Gilliam T.C., Levine B. Cloning and genomic organization of beclin 1, a candidate tumor suppressor gene on chromosome 17q21. Genomics 1999, 59:59-65.
14. Yue Z., Jin S., Yang C., Levine A.J., Heintz N. Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc Natl Acad Sci U S A 2003, 100:15077-15082.
15. Sato K., Tsuchihara K., Fujii S., Sugiyama M., Goya T., Atomi Y., Ueno T., Ochiai A., Esumi H. Autophagy is activated in colorectal cancer cells and contributes to the tolerance to nutrient deprivation. Cancer Res 2007, 67:9677-9684.
16. Jin S., White E. Tumor suppression by autophagy through the management of metabolic stress. Autophagy 2008, 4:563-566.
17. Mathew R., Karp C.M., Beaudoin B., Vuong N., Chen G., Chen H.Y., Bray K., Reddy A., Bhanot G., Gelinas C., et al. Autophagy suppresses tumorigenesis through elimination of p62. Cell 2009, 137:1062-1075.
18. Komatsu M., Waguri S., Chiba T., Murata S., Iwata J., Tanida I., Ueno T., Koike M., Uchiyama Y., Kominami E., et al. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 2006, 441:880-884.
19. Hara T., Nakamura K., Matsui M., Yamamoto A., Nakahara Y., Suzuki-Migishima R., Yokoyama M., Mishima K., Saito I., Okano H., et al. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 2006, 441:885-889.
20. Kruse K.B., Dear A., Kaltenbrun E.R., Crum B.E., George P.M., Brennan S.O., McCracken A.A. Mutant fibrinogen cleared from the endoplasmic reticulum via endoplasmic reticulum-associated protein degradation and autophagy: an explanation for liver disease. Am J Pathol 2006, 168:1299-1308. quiz 1404-1295.
21. Kamimoto T., Shoji S., Hidvegi T., Mizushima N., Umebayashi K., Perlmutter D.H., Yoshimori T. Intracellular inclusions containing mutant alpha1-antitrypsin Z are propagated in the absence of autophagic activity. J Biol Chem 2006, 281:4467-4476.
22. Hayflick L., Moorhead P.S. The serial cultivation of human diploid cell strains. Exp Cell Res 1961, 25:585-621.
23. Collado M., Serrano M. The power and the promise of oncogene-induced senescence markers. Nat Rev Cancer 2006, 6:472-476.
24. Young A.R., Narita M., Ferreira M., Kirschner K., Sadaie M., Darot J.F., Tavare S., Arakawa S., Shimizu S., Watt F.M., et al. Autophagy mediates the mitotic senescence transition. Genes Dev 2009, 23:798-803.
25. Courtois-Cox S., Genther Williams S.M., Reczek E.E., Johnson B.W., McGillicuddy L.T., Johannessen C.M., Hollstein P.E., MacCollin M., Cichowski K. A negative feedback signaling network underlies oncogene-induced senescence. Cancer Cell 2006, 10:459-472.
26. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell 2000, 100:57-70.
27. Buell J.F., Gross T.G., Woodle E.S. Malignancy after transplantation. Transplantation 2005, 80:S254-264.
28. Reiman J.M., Kmieciak M., Manjili M.H., Knutson K.L. Tumor immunoediting and immunosculpting pathways to cancer progression. Semin Cancer Biol 2007, 17:275-287.
29. Lu B., Finn O.J. T-cell death and cancer immune tolerance. Cell Death Differ 2008, 15:70-79.
30. Rentzsch C., Kayser S., Stumm S., Watermann I., Walter S., Stevanovic S., Wallwiener D., Guckel B. Evaluation of pre-existent immunity in patients with primary breast cancer: molecular and cellular assays to quantify antigen-specific T lymphocytes in peripheral blood mononuclear cells. Clin Cancer Res 2003, 9:4376-4386.
31. Beckhove P., Feuerer M., Dolenc M., Schuetz F., Choi C., Sommerfeldt N., Schwendemann J., Ehlert K., Altevogt P., Bastert G., et al. Specifically activated memory T cell subsets from cancer patients recognize and reject xenotransplanted autologous tumors. J Clin Invest 2004, 114:67-76.
32. Caballero O.L., Chen Y.T. Cancer/testis (CT) antigens: potential targets for immunotherapy. Cancer Sci 2009, 100:2014-2021.
33. Vella L.A., Yu M., Fuhrmann S.R., El-Amine M., Epperson D.E., Finn O.J. Healthy individuals have T-cell and antibody responses to the tumor antigen cyclin B1 that when elicited in mice protect from cancer. Proc Natl Acad Sci U S A 2009, 106:14010-14015.
34. Goodell V., Salazar L.G., Urban N., Drescher C.W., Gray H., Swensen R.E., McIntosh M.W., Disis M.L. Antibody immunity to the p53 oncogenic protein is a prognostic indicator in ovarian cancer. J Clin Oncol 2006, 24:762-768.
35. Ishigami S., Natsugoe S., Tokuda K., Nakajo A., Che X., Iwashige H., Aridome K., Hokita S., Aikou T. Prognostic value of intratumoral natural killer cells in gastric carcinoma. Cancer 2000, 88:577-583.
36. Shafer-Weaver K., Anderson M., Malyguine A., Hurwitz A.A. T cell tolerance to tumors and cancer immunotherapy. Adv Exp Med Biol 2007, 601:357-368.
37. Crawford D.H. Biology and disease associations of Epstein-Barr virus. Philos Trans R Soc Lond B Biol Sci 2001, 356:461-473.
38. Paludan C., Schmid D., Landthaler M., Vockerodt M., Kube D., Tuschl T., Munz C. Endogenous MHC class II processing of a viral nuclear antigen after autophagy. Science 2005, 307:593-596.
39. Dorfel D., Appel S., Grunebach F., Weck M.M., Muller M.R., Heine A., Brossart P. Processing and presentation of HLA class I and II epitopes by dendritic cells after transfection with in vitro-transcribed MUC1 RNA. Blood 2005, 105:3199-3205.
40. Schmid D., Pypaert M., Munz C. Antigen-loading compartments for major histocompatibility complex class II molecules continuously receive input from autophagosomes. Immunity 2007, 26:79-92.
41. Pua H.H., Dzhagalov I., Chuck M., Mizushima N., He Y.W. A critical role for the autophagy gene Atg5 in T cell survival and proliferation. J Exp Med 2007, 204:25-31.
42. Nedjic J., Aichinger M., Emmerich J., Mizushima N., Klein L. Autophagy in thymic epithelium shapes the T-cell repertoire and is essential for tolerance. Nature 2008, 455:396-400.
43. Watanabe K., Ichinose S., Hayashizaki K., Tsubata T. Induction of autophagy by B cell antigen receptor stimulation and its inhibition by costimulation. Biochem Biophys Res Commun 2008, 374:274-281.
44. Sanjuan M.A., Dillon C.P., Tait S.W., Moshiach S., Dorsey F., Connell S., Komatsu M., Tanaka K., Cleveland J.L., Withoff S., et al. Toll-like receptor signalling in macrophages links the autophagy pathway to phagocytosis. Nature 2007, 450:1253-1257.
45. Qu X., Zou Z., Sun Q., Luby-Phelps K., Cheng P., Hogan R.N., Gilpin C., Levine B. Autophagy gene-dependent clearance of apoptotic cells during embryonic development. Cell 2007, 128:931-946.
46. Cadwell K., Liu J.Y., Brown S.L., Miyoshi H., Loh J., Lennerz J.K., Kishi C., Kc W., Carrero J.A., Hunt S., et al. A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells. Nature 2008, 456:259-263.
47. Pearce E.L., Walsh M.C., Cejas P.J., Harms G.M., Shen H., Wang L.S., Jones R.G., Choi Y. Enhancing CD8 T-cell memory by modulating fatty acid metabolism. Nature 2009, 460:103-107.
48. Araki K., Turner A.P., Shaffer V.O., Gangappa S., Keller S.A., Bachmann M.F., Larsen C.P., Ahmed R. mTOR regulates memory CD8 T-cell differentiation. Nature 2009, 460:108-112.
49. Cuervo A.M., Bergamini E., Brunk U.T., Droge W., Ffrench M., Terman A. Autophagy and aging: the importance of maintaining 'clean' cells. Autophagy 2005, 1:131-140.
50. McCay C.M., Crowell M.F., Maynard L.A. The effect of retarded growth upon length of lifespan and upon ultimate body size. J Nutr 1935, 10:63-79.
51. Pinkston J.M., Garigan D., Hansen M., Kenyon C. Mutations that increase the life span of C. elegans inhibit tumor growth. Science 2006, 313:971-975.
52. Hansen M., Chandra A., Mitic L.L., Onken B., Driscoll M., Kenyon C. A role for autophagy in the extension of lifespan by dietary restriction in C. elegans. PLoS Genet 2008, 4:e24.
53. Bartke A., Wright J.C., Mattison J.A., Ingram D.K., Miller R.A., Roth G.S. Extending the lifespan of long-lived mice. Nature 2001, 414:412.
54. Berrigan D., Perkins S.N., Haines D.C., Hursting S.D. Adult-onset calorie restriction and fasting delay spontaneous tumorigenesis in p53-deficient mice. Carcinogenesis 2002, 23:817-822.
55. Colman R.J., Anderson R.M., Johnson S.C., Kastman E.K., Kosmatka K.J., Beasley T.M., Allison D.B., Cruzen C., Simmons H.A., Kemnitz J.W., et al. Caloric restriction delays disease onset and mortality in rhesus monkeys. Science 2009, 325:201-204.
56. Alvers A.L., Fishwick L.K., Wood M.S., Hu D., Chung H.S., Dunn W.A., Aris J.P. Autophagy and amino acid homeostasis are required for chronological longevity in Saccharomyces cerevisiae. Aging Cell 2009, 8:353-369.
57. Hars E.S., Qi H., Ryazanov A.G., Jin S., Cai L., Hu C., Liu L.F. Autophagy regulates ageing in C. elegans. Autophagy 2007, 3:93-95.
58. Juhasz G., Erdi B., Sass M., Neufeld T.P. Atg7-dependent autophagy promotes neuronal health, stress tolerance, and longevity but is dispensable for metamorphosis in Drosophila. Genes Dev 2007, 21:3061-3066.
59. Colotta F., Allavena P., Sica A., Garlanda C., Mantovani A. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 2009, 30:1073-1081.
60. Cohen H.Y., Miller C., Bitterman K.J., Wall N.R., Hekking B., Kessler B., Howitz K.T., Gorospe M., de Cabo R., Sinclair D.A. Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science 2004, 305:390-392.
61. Nemoto S., Fergusson M.M., Finkel T. Nutrient availability regulates SIRT1 through a forkhead-dependent pathway. Science 2004, 306:2105-2108.
62. Lee I.H., Cao L., Mostoslavsky R., Lombard D.B., Liu J., Bruns N.E., Tsokos M., Alt F.W., Finkel T. A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy. Proc Natl Acad Sci U S A 2008, 105:3374-3379.
63. Lee I.H., Finkel T. Regulation of autophagy by the p300 acetyltransferase. J Biol Chem 2009, 284:6322-6328.
64. Pan M.H., Ho C.T. Chemopreventive effects of natural dietary compounds on cancer development. Chem Soc Rev 2008, 37:2558-2574.
65. Davis C.D. Nutritional interactions: credentialing of moleular targets for cancer prevention. Soc Exp Biol Med 2007, 232:176-183.
66. Hannigan A.M., Gorski S.M. Macroautophagy: the key ingredient to a healthy diet?. Autophagy 2009, 5:140-151.
67. Singletary K., Milner J. Diet, autophagy, and cancer: a review. Cancer Epidemiol Biomarkers Prev 2008, 17:1596-1610.
68. White E., DiPaola R.S. The double-edged sword of autophagy modulation in cancer. Clin Cancer Res 2009, 15:5308-5316.
69. Park M.A., Zhang G., Martin A.P., Hamed H., Mitchell C., Hylemon P.B., Graf M., Rahmani M., Ryan K., Liu X., et al. Vorinostat and sorafenib increase ER stress, autophagy and apoptosis via ceramide-dependent CD95 and PERK activation. Cancer Biol Ther 2008, 7:1648-1662.
70. Harrison D.E., Strong R., Sharp Z.D., Nelson J.F., Astle C.M., Flurkey K., Nadon N.L., Wilkinson J.E., Frenkel K., Carter C.S., et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 2009, 460:392-395.
71. Maclean K.H., Dorsey F.C., Cleveland J.L., Kastan M.B. Targeting lysosomal degradation induces p53-dependent cell death and prevents cancer in mouse models of lymphomagenesis. J Clin Invest 2008, 118:79-88.
72. Geser A., Brubaker G., Draper C.C. Effect of a malaria suppression program on the incidence of African Burkitt's lymphoma. Am J Epidemiol 1989, 129:740-752.
73. Evans J.M., Donnelly L.A., Emslie-Smith A.M., Alessi D.R., Morris A.D. Metformin and reduced risk of cancer in diabetic patients. BMJ 2005, 330:1304-1305.
74. Bowker S.L., Majumdar S.R., Veugelers P., Johnson J.A. Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin. Diabetes Care 2006, 29:254-258.
75. Landman G.W., Kleefstra N., van Hateren K.J., Groenier K.H., Gans R.O., Bilo H.J. Metformin associated with lower cancer mortality in type 2 diabetes (ZODIAC-16). Diabetes Care 2009.
76. Stumvoll M., Nurjhan N., Perriello G., Dailey G., Gerich J.E. Metabolic effects of metformin in non-insulin-dependent diabetes mellitus. N Engl J Med 1995, 333:550-554.
77. Buzzai M., Jones R.G., Amaravadi R.K., Lum J.J., DeBerardinis R.J., Zhao F., Viollet B., Thompson C.B. Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth. Cancer Res 2007, 67:6745-6752.